Clinical Trials Browser

Phase 2 × Gastrointestinal Neoplasms × regorafenib × Clear all

NCT02241720 2018-01-11

Regorafenib Second Line Treatment of Metastatic or Advanced Upper GI Cancers

Phase 2 Terminated

5 enrolled 6 charts

Gastrointestinal

Gastrointestinal Neoplasms